NDC 65162-698-39 - Gabapentin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
65162-698
Requested NDC
65162-698-39
Package NDCs from labels
65162-698-90, 65162-698-39, 65162-698-54
Manufacturer
Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLC
Effective date
2025-05-13
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Gabapentin - Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLCAmneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLC2025-05-13HUMAN PRESCRIPTION DRUG LABEL
Gabapentin - ATLANTIC BIOLOGICALS CORP.ATLANTIC BIOLOGICALS CORP.2023-04-12HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
65162-698-39Gabapentin5 mL in 1 CUP, UNIT-DOSESOLUTION528
65162-698-54Gabapentin50 in 1 CARTONSOLUTION5028
65162-698-90Gabapentin473 mL in 1 BOTTLESOLUTION47328

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
65162-698GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS LLC]27Current NDC, Legacy NDC, 3 package rows20241006_772d9e7a-3811-455a-99e6-f2a3d0769b9b.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
65162-698-90ML - Milliliter65162-698781d1576-35f2-4340-9bb7-8435d1507cd512012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
GABAPENTINACTIVE INGREDIENT6CW7F3G59XGABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]7
GABAPENTINACTIVE MOIETY6CW7F3G59XGABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]7
ACESULFAME POTASSIUMINACTIVE INGREDIENT23OV73Q5G9GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]7
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORMINACTIVE INGREDIENTK679OBS311GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]7
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CBGABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]7
POTASSIUM SORBATEINACTIVE INGREDIENT1VPU26JZZ4GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]7
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IGABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]7

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 7 of 28 · 541 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GabapentinGABAPENTINSt. Mary's Medical Park Pharmacyb7a29b99-ce23-950e-e053-2995a90a19342026-06-09Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINCoupler LLC5385e27c-f2fa-32d5-e063-6294a90a0a8c2026-06-05Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
REFRESH CELLUVISCCARBOXYMETHYLCELLULOSE SODIUMAllergan, Inc.b32ed9e8-d091-4f16-b416-5a62cdfee49a2026-06-05WarningsExact identifier
unii: K679OBS311
GABAPENTINGABAPENTINSt. Mary's Medical Park Pharmacy07f07d15-ee91-8c2a-e063-6394a90a46242026-06-03Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINCardinal Health 107, LLCb2da7d96-73ad-4f44-8784-160a384a09612026-06-03Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINSt. Mary's Medical Park Pharmacyf93eaa4f-cc1a-10ab-e053-6394a90a5ffc2026-06-02Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINDirect_Rxf8998c1c-c359-6f01-e053-6294a90aebf42026-06-01Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
gabapentinGABAPENTINProficient Rx LPc7674ea5-276b-4bb3-821b-4ac05c9e64e62026-06-01Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
C-More Lubricant Eye DropsCARBOXYMETHYLCELLULOSE SODIUM, GLYCERINPROFOUND NUTRITION LIMITED78f04ecb-da5e-468c-81fe-70f7c26b76c22026-06-01WarningsExact identifier
unii: K679OBS311
GabapentinGABAPENTINAmneal Pharmaceuticals LLC507bf6d0-e7a2-413d-9848-cd2445a1411d2026-05-30Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINLaurus Labs Limited07aa1bcc-df05-44fa-92d4-63894e0e6cd62026-05-28Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINA-S Medication Solutions03031adf-d36b-45ec-944e-dfce5a5de91a2026-05-28Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GABAPENTINGABAPENTINPangea Pharmaceuticals, LLC5eff7ad8-0d31-4372-82a2-ac9f549d87962026-05-22Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GABAPENTINGABAPENTINBryant Ranch Prepack397fd6d3-317b-4b61-a52b-3a09ca1d88a42026-05-22Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GABAPENTINGABAPENTINBryant Ranch Prepack13640281-26b4-402e-8f69-7c81cd6e03762026-05-22Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINAmici Pharma, Inc.1ea83c18-7107-41f4-8305-62725c1c45c82026-05-19Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
Muriaticum acidumHYDROCHLORIC ACIDBoiron8643bc58-bb0e-5c79-e053-2991aa0a02ae2026-05-19WarningsExact identifier
unii: QTT17582CB
GabapentinGABAPENTINCardinal Health 107, LLCd4f21e97-5e55-44c9-9b31-5f79ac2eb5122026-05-18Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
NeurontinGABAPENTINViatris Specialty LLC97935fd9-1d4a-43b6-a5d9-de994591187b2026-05-12Warnings, Adverse reactionsExact identifier
rxcui: 283523
unii: 6CW7F3G59X
GabapentinGABAPENTINCardinal Health 107, LLCeeb19a5a-b31d-4df8-9546-0b2b5eb5db072026-05-07Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.